CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3 enrolled
Drug / intervention
Transcranial Magnetic Stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04795908
NCT04795908N/ACompleted
CompareCT.gov

STOP-TIC Study: Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT

University of Florida·interventional·Posted Mar 12, 2021·Updated Apr 30, 2024

In Brief

A clinical study evaluating Transcranial Magnetic Stimulation and Comprehensive behavioral intervention for Tourette Syndrome. Completed, enrolled 3 participants across 1 site.

Detailed Summary

The investigator will apply 16 sessions of repetitive transcranial magnetic stimulation (rTMS) over 4 consecutive days for adult patients suffering from Tourette's Syndrome. Following rTMS, patients will undergo 8 sessions of Comprehensive Behavioral Intervention for Tics (CBIT) over 10 weeks via telemedicine. Clinical improvement in tic severity will be the primary outcome measure. Secondary outcome measures including underlying physiological effects will be measured via functional magnetic resonance imaginge (fMRI), high-density electroencephalograhy (HD-EEG), and TMS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTourette Syndrome
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 12, 2021
Enrollment StartDec 17, 2021
Primary CompletionJan 18, 2023
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.3 years ago

Interventions

Transcranial Magnetic Stimulationdevice

rTMS will be delivered using a MagStim Super Rapid2 TMS therapy system.

Comprehensive behavioral interventionbehavioral

Patients will receive CBIT with a therapist trained in CBIT. Each session will last about an hour and will be delivered remotely via telemedicine. Sessions will be tailed to the patient's individual needs.